Skip to main content
Clinical Trials/ACTRN12609000006246
ACTRN12609000006246
Completed
Phase 4

An evaluation of the safety and effectiveness of patient-controlled intranasal fentanyl for relieving pain in birthing women.

Western Health0 sites50 target enrollmentJanuary 6, 2009

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Childbirth
Sponsor
Western Health
Enrollment
50
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 6, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 18 years old and over;
  • Singleton pregnancy;
  • Term – at least 37 weeks;
  • Prima Gravida.

Exclusion Criteria

  • Failure to provide consent;
  • Complicated pregnancy – i.e. – no pregnancy induced hypertension, pre\-eclampsia, gestational diabetes mellitus;
  • Abnormal foetal positioning i.e. breech;
  • Placental abnormalities;
  • Non\-singleton pregnancy;
  • Allergy to opioid analgesia;
  • Bronchial asthma
  • Myasthenia gravis;
  • Opioid Tolerance including regular use of methadone, buprenorphine, heroin, morphine, oxycodone;
  • Chronic nasal problems i.e. hay\-fever, sinusitis, common cold;

Outcomes

Primary Outcomes

Not specified

Similar Trials